Developing any therapeutic, diagnostic or medical device in today’s world has risks, let alone one at the nanoscale. What are the unique risks and big opportunities for developing products at the nanoscale?
This month’s meeting will introduce the science, engineering and promise behind the development of healthcare products with nanometer dimensions. How small is that? It can be on the molecular level. Novel microscopes had to be developed in the early 1980’s so that scientists could see and manipulate materials in the nanometer dimensions, and by the late 1990’s a diverse range of consumer products started to become available, from computer chips to scratch-resistant glass coatings to faster recharging batteries.
Moderated by Michael Cima, Ph.D., David H. Koch Professor of Engineering, MIT, this MDg forum’s distinguished panel of presenters includes David P. Harding, Chief Commercial Officer, T2 Biosystems, Inc., Jarret Wright, Lab Manager, Thermal, Physical and Microscopy Group, Polymer Solutions Inc. and Stephen Zale, PhD, VP of Discovery and Research at BIND Therapeutics.
Send this to a friend